Item 1. | Security and Issuer |
This statement on Schedule 13D (this “Schedule 13D”) relates to the common stock, $0.01 par value per share (the “Common Stock”), of The Duckhorn Portfolio, Inc. (the “Issuer”). The address of the principal executive offices of the Issuer is 1201 Dowdell Lane, Saint Helena, California 94574.
Item 2. | Identity and Background |
(a) | This Schedule 13D is filed by Mallard Holdco, LLC (the “Reporting Person”), a Delaware limited liability company. |
The names of the managers of the Reporting Person are set forth on Schedule 1, which is incorporated herein by reference.
(b) | The principal business office of the Reporting Person and each of the managers of the Reporting Person is c/o TSG Consumer Partners, LLC, 1100 Larkspur Landing Circle Suite 360, Larkspur CA 94939. |
(c) | The principal business of the Reporting Person is holding company for interests in the Issuer. The principal occupation of each of the managers of the Reporting Person is set forth on Schedule 1. |
(d) | During the last five years, none of the Reporting Person nor any manager of the Reporting Person has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
(e) | During the last five years, none of the Reporting Person nor any manager of the Reporting Person was a party to a civil proceeding of a judicial of administrative body of competent jurisdiction and was not subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
(f) | The Reporting Person was organized in Delaware. The citizenship of each of the managers of the Reporting Person is set forth on Schedule 1. |
Item 3. | Source and Amount of Funds or Other Consideration |
The Issuer was incorporated in September 2016 as a direct subsidiary of the Reporting Person. In connection with a stock split related to the Issuer’s initial public offering on March 17, 2021 (the “IPO”), the Reporting Person received 96,098,790 shares of common stock of the Issuer. Immediately following the closing of the IPO, the Reporting Person beneficially owned 86,432,303 shares of Common Stock.
Item 4. | Purpose of Transaction |
The Reporting Person filed an initial Schedule 13G on February 4, 2022, which was amended on February 14, 2023 and February 14, 2024 (together, the “Schedule 13G”), with respect to the Issuer pursuant to Rule 13d-1(d) of the Exchange Act Rules. The Reporting Person is filing this Schedule 13D to supersede the Schedule 13G.
Voting Agreement
On October 6, 2024, the Issuer entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Issuer, Marlee Buyer, Inc. (“Parent”), and Marlee Merger Sub, Inc. (“Merger Sub”), pursuant to which Merger Sub will merge with and into the Issuer (the “Merger”), with the Issuer surviving the Merger. In connection with the transactions contemplated by the Merger Agreement, on October 6, 2024, certain investors of the Issuer, including the Reporting Person, in their capacity as stockholders of the Company, each entered into a voting and support agreement (the “Voting Agreement”) with Parent. Under the Voting Agreement, the Reporting Person committed to vote 50,497,784 shares of Common Stock, or 34.3% of the total Common Stock issued and outstanding, among other things, in favor of the adoption of the Merger Agreement and against any competing transaction or any other action, agreement or proposal which to its knowledge would reasonably be expected to prevent or materially impede or materially delay the consummation of the Merger or any of the other transactions contemplated by the Merger Agreement. Pursuant to the Amended and Restated Stockholders Agreement, dated as of November 16, 2023, by and among the Issuer, the Reporting Person and Brown-Forman Corporation (the “Stockholders Agreement”), the Reporting Person agreed with the Issuer that, in the event a definitive agreement contemplating a definitive sale of the Issuer was submitted to stockholders of the Issuer for adoption or approval, it would vote 11.7% of the total Common Stock issued and outstanding (to the extent beneficially owned by the Reporting Person) pro rata in accordance with the vote of all other issued and outstanding voting securities of the Issuer (excluding the Reporting Person’s voting securities).
The Voting Agreement also includes certain restrictions on transfer of the shares of Common Stock held by the Reporting Person. The Voting Agreement terminates in certain circumstances, including in connection with the Issuer’s termination of the Merger Agreement in order to accept a superior proposal. The stockholders that signed a Voting Agreement, including the Reporting Person, hold shares of Common Stock representing a majority of the Issuer’s outstanding voting power as of October 4, 2024.